7 Feb 2022 , 05:10 PM
Net profit of Glaxosmithkline Pharmaceuticals declined 3.94% to Rs 150.35 crore in the quarter ended December 2021 as against Rs 156.51 crore during the previous quarter ended December 2020. Sales rose 3.04% to Rs 815.92 crore in the quarter ended December 2021 as against Rs 791.87 crore during the previous quarter ended December 2020.
| Particulars | Quarter Ended | ||
| ? | Dec. 2021 | Dec. 2020 | % Var. |
| Sales | 815.92 | 791.87 | 3 |
| OPM % | 24.24 | 22.81 | – |
| PBDT | 219.62 | 211.00 | 4 |
| PBT | 201.75 | 193.46 | 4 |
| NP | 150.35 | 156.51 | -4 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
